Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.56 |
| ▸ | ADRA1A | P35348 | 3/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | DRD2 | P14416 | 2/20 | 0.41 |
| ▸ | DRD4 | P21917 | 2/20 | 0.41 |
| ▸ | DRD3 | P35462 | 2/20 | 0.41 |
| ▸ | MTNR1A | P48039 | 5/20 | 0.40 |
| ▸ | MTNR1B | P49286 | 5/20 | 0.40 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | ACHE | P22303 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7543096 | 0.83 | DRD2 (0.58) | CYP1A2ADRA1AKDM4EDRD2DRD4 | |
| Hydrochloric Acid SCHEMBL7540811 | 0.82 | DRD2 (0.57) | CYP1A2ADRA1AKDM4EDRD2DRD4 | |
| SCHEMBL7543110 | 0.82 | ADRA1A (0.44) | CYP1A2ADRA1ADRD2DRD4DRD3 | |
| SCHEMBL7546623 | 0.82 | HTR2A (0.45) | CYP1A2ADRA1ADRD2DRD4DRD3 | |
| SCHEMBL7541153 | 0.82 | ADRA1A (0.41) | CYP1A2ADRA1ADRD2DRD4DRD3 | |
| SCHEMBL7542176 | 0.79 | HTR2A (0.45) | CYP1A2ADRA1ADRD2DRD4DRD3 | |
| SCHEMBL7540836 | 0.78 | MTNR1A (0.65) | CYP1A2DRD2DRD4DRD3MTNR1A | |
| SCHEMBL22803028 | 0.78 | MTNR1A (0.65) | CYP1A2DRD2DRD4DRD3MTNR1A | |
| SCHEMBL9355020 | 0.77 | CYP1A2 (0.52) | CYP1A2ADRA1ADRD2DRD4DRD3 | |
| SCHEMBL9359251 | 0.77 | CYP1A2 (0.52) | CYP1A2ADRA1AKDM4EDRD2DRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0883599-B1 | AMINOTETRALIN DERIVATIVES AND COMPOSITIONS AND METHOD OF USE THEREOF | ASTRAZENECA AB (SE) | 2002-06-05 | — | — | EP | disclosed |
| EP-0883599-A1 | AMINOTETRALIN DERIVATIVES AND COMPOSITIONS AND METHOD OF USE THEREOF | ZENECA LIMITED (GB) | 1998-12-16 | — | — | EP | disclosed |
| US-5807897-A | MUSCULAR DISORDERS | ZENECA LIMITED (GB) | 1998-09-15 | — | — | US | disclosed |
| WO-1997031887-A1 | AMINOTETRALIN DERIVATIVES AND COMPOSITIONS AND METHOD OF USE THEREOF | ZENECA LIMITED (GB) | 1997-09-04 | — | — | WO | disclosed |